Imaging: Prostate Cancer VL

PSMA PET Imaging in Clinical Practice - Thomas Hope & Jeremie Calais

Details
Matthew Cooperberg is joined by Tom Hope and Jeremie Calais in a discussion PSMA PET agents that have been approved by the US Food and Drug Administration (FDA) and their effect on clinical practice. Positron Emission Tomography (PET) nuclear imaging technique is used to detect prostate cancer. Combining PET with Prostate Specific Membrane Antigen (PSMA) helps doctors to specifically identify pros...

PSMA PET Scan Imaging in Prostate Cancer - Ashley Ross

Details
Ashley Ross and Alicia Morgans discuss the use of PSMA PET scans in the metastatic CRPC and how the recommendations and guidance have evolved in the NCCN guidelines. Dr. Ross gives an overview of the relevant clinical trials and FDA approvals of key radiotracers and their impact on clinical practice and treatment sequencing, as well as the impact of supply line problems on implementation. Biograph...

The Role of Imaging Before and After Diagnosis of Localized Prostate Cancer - Masoom Haider

Details
Masoom Haider, a presenter at the 2022 AdMeTech Global Summit for Prostate Cancer, joins Phillip Koo to discuss the upcoming 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer where he'll present on radiomics and machine learning. Dr. Haider provides a high level overview of radiomics and the potential there is within this field. In November 1997, AdMeTech Foundation was est...

Prostate Cancer and the Role of MRI, Molecular Imaging, and Their Integration - Peter Choyke

Details
Peter Choyke, a presenter at the 2022 AdMeTech Global Summit for Prostate Cancer, joins Phillip Koo to discuss prostate MRI and the upcoming 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer. In November 1997, AdMeTech Foundation was established as a Nonprofit Corporation for the Advancement of Medical Technologies, with a priority focus on the advancement of prostate cance...

Smarter Screening In Prostate Cancer - Sigrid Carlsson

Details
Sigrid Carlsson joins Phillip Koo in a discussion on Smart Screening in Prostate Cancer, a session being highlighted at the upcoming 6th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer taking place virtually September 22-24. The pair discuss challenges with screening today that require clinicians to be smarter about screening including the risk of overdiagnosis, incorporating...

MRI and Active Surveillance for Prostate Cancer - Robert Reiter

Details
Rob Reiter and Alicia Morgans discuss the use of MRI and active surveillance in prostate cancer treatment. Dr. Reiter explains how MRI is used to improve proper patient selection for active surveillance. He also discusses how he was an early adopter of MRI and how he incorporates an MRI-guided biopsy program in his practice. In conclusion, Dr. Reiter and Dr. Morgans agree it’s important to note th...

Impact of Next Generation Imaging: What Is the Optimal (Current) Tracer for PET-Based Imaging for Staging Presentation - Ken Herrmann

Details
Ken Herrmann presents an update on the current data regarding optimal PSMA PET tracers. Biographies: Ken Herrmann, MD, MBA, Professor and Chair of the Department of Nuclear Medicine, Universitatsklinikum Essen, Essen, Germany Related Content: APCCC 2022: Impact of Next Generation Imaging: What Is the Optimal (Current) Tracer for PET-Based Imaging for Staging The Mechanism of PSMA PET for Prostate...

First Standardized Framework Measuring PSMA PET/CT Response in Metastatic Castration‑Resistant Prostate Cancer - Wolfgang Fendler and Andrei Gafita

Details
Wolfgang Fendler and Andrei Gafita join Phillip Koo in a discussion on the Journal of Nuclear Medicine publication "Measuring response in metastatic castration‑resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria". This study received partial funding from the Prostate Cancer Foundation (PCF). In order to move PSMA PET forward and shif...

Incorporating Molecular Testing into Clinical Practice for Prostate Cancer - Elena Castro & Collin Pritchard

Details
Colin Pritchard and Elena Castro join Alicia Morgans in a conversation on incorporating molecular testing into our treatment paradigms for men with prostate cancer. There is a need to optimize testing, to eliminate any burdens to practicing clinicians in their daily work. Drs. Pritchard, Castro, and Morgans also discuss tissue-based and blood-based tests and overcoming the challenges of getting ti...

Future Perspectives in Prostate Imaging in Developing Countries - Ronaldo Hueb Baroni

Details
Ronaldo Baroni joins Phillip Koo at the 13th Uro-Oncology Congress in São Paulo, Brazil in a discussion highlighting Dr Baroni's lecture he gave on future perspectives in prostate imaging. Prostate MRI is already established as the standard modality for prostate detection prior to biopsy. Future perspectives include more rational and widespread use of prostate MRI including a more widely available...
email news signup